Alignment Healthcare (ALHC) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ALHC Stock Forecast


Alignment Healthcare (ALHC) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $24.50, with a high of $30.00 and a low of $18.00. This represents a 43.11% increase from the last price of $17.12.

- $6 $12 $18 $24 $30 High: $30 Avg: $24.5 Low: $18 Last Closed Price: $17.12

ALHC Stock Rating


Alignment Healthcare stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 1 Strong Buy (6.25%), 13 Buy (81.25%), 2 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 2 13 1 Strong Sell Sell Hold Buy Strong Buy

ALHC Price Target Upside V Benchmarks


TypeNameUpside
StockAlignment Healthcare43.11%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks30.38%

Price Target Trends


1M3M12M
# Anlaysts-49
Avg Price Target-$26.75$23.00
Last Closing Price$17.12$17.12$17.12
Upside/Downside-56.25%34.35%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26292--13
Feb, 26192--12
Jan, 26292--13
Dec, 25292--13
Nov, 25193--13
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 30, 2026Robert W. Baird$28.00$22.5024.44%63.55%
Jan 22, 2026KeyBanc$28.00$23.3020.17%63.55%
Jan 14, 2026UBS$21.00$20.920.38%22.66%
Jan 06, 2026Jessica TassanPiper Sandler$30.00$21.0042.86%75.23%
Nov 03, 2025Scott FidelGoldman Sachs$22.00$16.8630.49%28.50%
Oct 31, 2025Barclays$18.00$16.886.64%5.14%
Oct 31, 2025Kevin CaliendoUBS$18.00$18.53-2.86%5.14%
Oct 14, 2025Goldman Sachs$21.00$17.3121.32%22.66%
Aug 25, 2025Matthew GillmorKeyBanc$21.00$15.5834.79%22.66%
Mar 04, 2025Piper Sandler$21.00$15.7533.33%22.66%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 22, 2026KeyBancOverweightOverweighthold
Jan 16, 2026Cowen & Co.BuyBuyhold
Jan 14, 2026UBSNeutralNeutralhold
Jan 06, 2026Piper SandlerOverweightOverweighthold
Nov 24, 2025KeyBancOverweightOverweighthold
Nov 03, 2025Goldman SachsBuyBuyhold
Oct 31, 2025UBSNeutralNeutralhold
Oct 14, 2025Goldman SachsBuyinitialise
Aug 25, 2025KeyBancSector WeightOverweightupgrade
Mar 04, 2025Piper SandlerOverweightOverweighthold

Financial Forecast


EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.14$-0.83$-0.79$-0.67----
Avg Forecast$-1.00$-0.70$-0.66$-0.68$-0.53$-0.39$-0.18$0.74
High Forecast$-0.97$-0.67$-0.63$-0.64$-0.27$-0.10$0.29$0.79
Low Forecast$-1.05$-0.74$-0.67$-0.73$-0.65$-0.62$-0.54$0.70
Surprise %14.00%18.57%19.70%-1.47%----

Revenue Forecast

$1B $2B $3B $5B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.17B$1.43B$1.82B$2.70B$3.95B---
Avg Forecast$1.14B$1.41B$1.80B$2.68B$3.48B$4.29B$5.17B$6.24B
High Forecast$1.18B$1.47B$1.82B$2.69B$3.60B$4.29B$5.42B$6.55B
Low Forecast$1.12B$1.36B$1.79B$2.67B$3.32B$4.29B$4.97B$6.00B
Surprise %2.42%1.49%1.20%0.98%13.43%---

Net Income Forecast

$-200M $-130M $-60M $10M $80M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-195.29M$-149.55M$-148.02M$-128.03M$-724.00K---
Avg Forecast$-186.80M$-130.50M$-121.43M$-127.52M$-95.41M$-79.65M$-35.38M$137.80M
High Forecast$-181.47M$-124.51M$-117.46M$-120.02M$-50.86M$-19.52M$54.00M$146.54M
Low Forecast$-195.97M$-137.66M$-125.40M$-135.02M$-120.79M$-115.15M$-100.56M$130.97M
Surprise %4.55%14.60%21.89%0.40%-99.24%---

ALHC Forecast FAQ


Is Alignment Healthcare stock a buy?

Alignment Healthcare stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 13 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alignment Healthcare is a favorable investment for most analysts.

What is Alignment Healthcare's price target?

Alignment Healthcare's price target, set by 16 Wall Street analysts, averages $24.5 over the next 12 months. The price target range spans from $18 at the low end to $30 at the high end, suggesting a potential 43.11% change from the previous closing price of $17.12.

How does Alignment Healthcare stock forecast compare to its benchmarks?

Alignment Healthcare's stock forecast shows a 43.11% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (30.38%).

What is the breakdown of analyst ratings for Alignment Healthcare over the past three months?

  • March 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 8.33% Strong Buy, 75.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Alignment Healthcare’s EPS forecast?

Alignment Healthcare's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.39, marking a 0% decrease from the reported $0 in 2025. Estimates for the following years are $-0.18 in 2027, and $0.74 in 2028.

What is Alignment Healthcare’s revenue forecast?

Alignment Healthcare's average annual revenue forecast for its fiscal year ending in December 2026 is $4.29B, reflecting a 8.58% increase from the reported $3.95B in 2025. The forecast for 2027 is $5.17B, and $6.24B for 2028.

What is Alignment Healthcare’s net income forecast?

Alignment Healthcare's net income forecast for the fiscal year ending in December 2026 stands at $-79.649M, representing an 10901.23% increase from the reported $-724K in 2025. Projections indicate $-35.38M in 2027, and $137.8M in 2028.